Targeted Oncology13d
Poor Outcomes Seen in BRAF V600E-Mutant mCRC With Systemic Therapy
Patients with BRAF V600E-mutant metastatic colorectal cancer experienced poor clinical outcomes with systemic therapy, ...
Medindia44m
Rare Systemic Mastocytosis: A Hidden Cause of Bone Loss
Explore a rare case of systemic mastocytosis in a young adult, highlighting its role in unexplained osteoporosis and the need for early testing.
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma ...
Healio10d
Menopausal hormone therapy may increase risks for lupus, systemic sclerosis
The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of ...
emjreviews.com3d
Women on Menopausal Hormone Therapy Face Higher Risk of Lupus and Scleroderma
A NEW Swedish study has found that menopausal hormone therapy (MHT) may be associated with an increased risk of developing ...
Pharm Exec8d
FDA Grants Fast Track Designation to Adicet Bio’s CAR T-cell Therapy for Systemic Lupus Erythematosus
The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...
EurekAlert!1d
Severe osteoporosis as a manifestation of systemic mastocytosis
A new case report was published in Oncoscience's Volume 12 on February 4, 2025, titled “Breaking point: Systemic mastocytosis manifesting as severe osteoporosis.” ...